October 30th, 2026Disability, Economic Toll of Multimorbidity Climb in Older Adults Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.Read more
October 30th, 2026October FDA Approvals Bring Advances Across 5 SpecialtiesOctober's FDA approvals included the introduction of 5 non-oncology treatment options across specialties. Read more
October 30th, 2026FAQ: PBM Reform, 340B, and Medicare Shifts Payers Face in 2027PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know heading into 2027.Read more
October 30th, 2026Bispecific Program Design Varies by Practice Size, Experts SayBispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for the Bispecifics Network.Read more
October 30th, 2026Shortening the Road to a Bipolar Diagnosis: Justin T. Ray, PMHNP-BCBipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and keep patients on treatment.Read more
October 30th, 2026Vibegron Persistence Near 60% at 1 Year in Real-World OAB StudyA phase 4 study found 69% of patients with OAB were consistently satisfied with vibegron at 12 months, with exploratory persistence of 59.8%.Read more
October 30th, 2026Machine Learning Models Flag Nonobese MASLD Using Routine Blood TestsTwo machine learning models identifies MASLD in lean adults using 8 routine clinical measurements.Read more
October 30th, 2026Pharmacists Take On Education and Toxicity Triage in Bispecific CarePharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity triage in bispecific care.Read more